Type 2 diabetes

In a recent Phase 3 trial, Eli Lilly's once-weekly insulin efsitora showed promising results in reducing hemoglobin A1C levels...

In a groundbreaking announcement, Eli Lilly revealed that its weekly insulin injection, efsitora alfa, demonstrated similar results to daily...

In a major development, Eli Lilly & Co.'s experimental once-weekly insulin, efsitora alfa, has shown comparable effectiveness to daily...

Insulet's stock soars 7.5% after FDA clears its automated insulin delivery system for type 2 diabetes management, making Omnipod...

Lead: How much drinking is bad for you? Scientists are issuing dire warnings about the potential health risks of...

Lead: A new study published in Nature Medicine reveals that even mild Covid infections can lead to health problems...

In groundbreaking news, Novo Nordisk's Ozempic drug has proven to slow down chronic kidney disease progression and reduce the...

New research reveals that over 76% of young adults prescribed GLP-1 drugs last year were women, raising concerns about...

Lead: A groundbreaking trial by Novo Nordisk reveals that its weight-loss drug, Ozempic, reduces the risk of kidney disease-related...

Lead: A groundbreaking Cognitive Behavioral Therapy platform by Better Therapeutics has received Breakthrough Device Designation from the FDA for...